View Financial HealthMisr Fertilizer Production 배당 및 자사주 매입배당 기준 점검 2/6Misr Fertilizer Production 수익으로 충분히 충당되는 현재 수익률 5.77% 보유한 배당금 지급 회사입니다. 다음 지급일은 30th September, 2026 이며 배당락일은 다음과 같습니다. 4th May, 2026.핵심 정보5.8%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률5.8%배당 성장률29.5%다음 배당 지급일30 Sep 26배당락일04 May 26주당 배당금n/a배당 성향64%최근 배당 및 자사주 매입 업데이트Upcoming Dividend • Mar 27Upcoming dividend of ج.م2.00 per shareEligible shareholders must have bought the stock before 03 April 2024. Payment date: 07 April 2024. Payout ratio is a comfortable 46% but the company is paying out more than the cash it is generating. Trailing yield: 3.1%. Lower than top quartile of Egyptian dividend payers (6.3%). Lower than average of industry peers (4.9%).Upcoming Dividend • May 03Upcoming dividend of ج.م15.00 per share at 8.6% yieldEligible shareholders must have bought the stock before 10 May 2023. Payment date: 14 May 2023. Trailing yield: 8.6%. Within top quartile of Egyptian dividend payers (8.1%). Higher than average of industry peers (6.8%).Upcoming Dividend • Mar 31Inaugural dividend of ج.م7.00 per shareEligible shareholders must have bought the stock before 07 April 2022. Payment date: 10 April 2022. The company is not currently making a profit but it is cash flow positive. The company last paid an ordinary dividend in April 2017. The average dividend yield among industry peers is 4.6%.Upcoming Dividend • Apr 19Inaugural dividend of ج.م3.50 per shareEligible shareholders must have bought the stock before 26 April 2021. Payment date: 28 April 2021. The company last paid an ordinary dividend in May 2019. The average dividend yield among industry peers is 5.9%.모든 업데이트 보기Recent updatesPrice Target Changed • May 20Price target increased by 16% to ج.م36.78Up from ج.م31.83, the current price target is an average from 4 analysts. New target price is 15% below last closing price of ج.م43.50. Stock is up 57% over the past year. The company is forecast to post earnings per share of ج.م6.00 for next year compared to ج.م3.94 last year.Board Change • May 20No independent directorsThere are 7 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: No independent directors. 11 non-independent directors. Director Hussein Mohamed Abdel Salam Badawi was the last director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity.공시 • Mar 13Misr Fertilizer Production Company, Annual General Meeting, Apr 06, 2026Misr Fertilizer Production Company, Annual General Meeting, Apr 06, 2026, at 15:30 Egypt Standard Time. Location: cairo EgyptReported Earnings • May 17First quarter 2025 earnings released: EPS: ج.م1.35 (vs ج.م3.68 in 1Q 2024)First quarter 2025 results: EPS: ج.م1.35 (down from ج.م3.68 in 1Q 2024). Revenue: ج.م6.34b (up 32% from 1Q 2024). Net income: ج.م2.81b (down 63% from 1Q 2024). Profit margin: 44% (down from 159% in 1Q 2024). Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Chemicals industry in Africa. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth.Board Change • May 14No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 9 non-independent directors. Director Yasser El-Din was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Mar 24Misr Fertilizer Production Company, Annual General Meeting, Apr 12, 2025Misr Fertilizer Production Company, Annual General Meeting, Apr 12, 2025, at 12:00 Egypt Standard Time. Location: cairo EgyptNew Risk • Oct 08New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.3% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings are forecast to decline by an average of 0.3% per year for the foreseeable future. High level of non-cash earnings (32% accrual ratio). Minor Risk Dividend is not well covered by cash flows (236% cash payout ratio).Reported Earnings • May 27First quarter 2024 earnings released: EPS: ج.م3.68 (vs ج.م1.18 in 1Q 2023)First quarter 2024 results: EPS: ج.م3.68 (up from ج.م1.18 in 1Q 2023). Revenue: ج.م4.80b (down 5.7% from 1Q 2023). Net income: ج.م7.65b (up 212% from 1Q 2023). Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in Egypt. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has increased by 82% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • May 19Investor sentiment improves as stock rises 29%After last week's 29% share price gain to ج.م51.82, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 640% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م23.36 per share.New Risk • May 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Egyptian stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (193% cash payout ratio). Share price has been volatile over the past 3 months (11% average weekly change).Valuation Update With 7 Day Price Move • Apr 24Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ج.م47.37, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 643% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م20.64 per share.Upcoming Dividend • Mar 27Upcoming dividend of ج.م2.00 per shareEligible shareholders must have bought the stock before 03 April 2024. Payment date: 07 April 2024. Payout ratio is a comfortable 46% but the company is paying out more than the cash it is generating. Trailing yield: 3.1%. Lower than top quartile of Egyptian dividend payers (6.3%). Lower than average of industry peers (4.9%).Valuation Update With 7 Day Price Move • Mar 18Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to ج.م48.30, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 688% over the past three years.Valuation Update With 7 Day Price Move • Feb 28Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ج.م62.13, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 835% over the past three years.Reported Earnings • Feb 20Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: ج.م2.87 (down from ج.م31.67 in FY 2022). Revenue: ج.م5.96b (down 68% from FY 2022). Net income: ج.م5.97b (down 18% from FY 2022). Revenue missed analyst estimates by 67%. Earnings per share (EPS) also missed analyst estimates by 91%. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 7.3% growth forecast for the Chemicals industry in Egypt. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Jan 22Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ج.م85.03, the stock trades at a forward P/E ratio of 3x. Average forward P/E is 7x in the Chemicals industry in Egypt. Total returns to shareholders of 54% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م132 per share.New Risk • Jan 08New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 8x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (29% average weekly change). Shareholders have been substantially diluted in the past year (over 8x increase in shares outstanding). Minor Risk Dividend is not well covered by cash flows (394% cash payout ratio).Buying Opportunity • Dec 28Now 92% undervalued after recent price dropOver the last 90 days, the stock is down 97%. The fair value is estimated to be ج.م122, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 40% over the last 3 years. Earnings per share has grown by 43%. For the next 3 years, revenue is forecast to grow by 8.1% per annum. Earnings is also forecast to grow by 2.4% per annum over the same time period.Valuation Update With 7 Day Price Move • Dec 10Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ج.م446, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 7x in the Chemicals industry in Egypt. Total returns to shareholders of 860% over the past three years.Reported Earnings • Dec 02Third quarter 2023 earnings released: EPS: ج.م5.47 (vs ج.م5.78 in 3Q 2022)Third quarter 2023 results: EPS: ج.م5.47 (down from ج.م5.78 in 3Q 2022). Revenue: ج.م3.82b (up 5.3% from 3Q 2022). Net income: ج.م1.25b (down 5.5% from 3Q 2022). Profit margin: 33% (down from 37% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.0% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Egypt. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has increased by 120% per year, which means it is tracking significantly ahead of earnings growth.Price Target Changed • Nov 29Price target increased by 15% to ج.م285Up from ج.م248, the current price target is an average from 7 analysts. New target price is 47% below last closing price of ج.م540. Stock is up 307% over the past year. The company is forecast to post earnings per share of ج.م31.76 for next year compared to ج.م31.67 last year.Valuation Update With 7 Day Price Move • Oct 31Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ج.م550, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 9x in the Chemicals industry in Egypt. Total returns to shareholders of 1,362% over the past three years.Valuation Update With 7 Day Price Move • Oct 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ج.م377, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 7x in the Chemicals industry in Egypt. Total returns to shareholders of 918% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م189 per share.Price Target Changed • Oct 10Price target increased by 7.5% to ج.م248Up from ج.م231, the current price target is an average from 7 analysts. New target price is 23% below last closing price of ج.م321. Stock is up 195% over the past year. The company is forecast to post earnings per share of ج.م31.99 for next year compared to ج.م31.67 last year.Valuation Update With 7 Day Price Move • Sep 19Investor sentiment improves as stock rises 33%After last week's 33% share price gain to ج.م333, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 7x in the Chemicals industry in Egypt. Total returns to shareholders of 756% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م202 per share.Price Target Changed • Sep 13Price target increased by 12% to ج.م247Up from ج.م221, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of ج.م251. Stock is up 136% over the past year. The company is forecast to post earnings per share of ج.م30.39 for next year compared to ج.م31.67 last year.Reported Earnings • Aug 31Second quarter 2023 earnings released: EPS: ج.م6.63 (vs ج.م7.18 in 2Q 2022)Second quarter 2023 results: EPS: ج.م6.63 (down from ج.م7.18 in 2Q 2022). Revenue: ج.م4.33b (down 3.7% from 2Q 2022). Net income: ج.م1.52b (down 7.7% from 2Q 2022). Profit margin: 35% (down from 37% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Egypt. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has increased by 68% per year, which means it is tracking significantly ahead of earnings growth.Price Target Changed • Jul 31Price target increased by 7.7% to ج.م227Up from ج.م211, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of ج.م230. Stock is up 131% over the past year. The company is forecast to post earnings per share of ج.م29.19 for next year compared to ج.م31.67 last year.Valuation Update With 7 Day Price Move • Jul 09Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ج.م190, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 410% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م151 per share.Price Target Changed • Jun 29Price target increased by 8.4% to ج.م195Up from ج.م180, the current price target is an average from 5 analysts. New target price is 16% below last closing price of ج.م232. Stock is up 146% over the past year. The company is forecast to post earnings per share of ج.م25.57 for next year compared to ج.م31.67 last year.New Risk • Jun 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Egyptian stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 6.2% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.9% average weekly change).Valuation Update With 7 Day Price Move • Jun 13Investor sentiment improves as stock rises 29%After last week's 29% share price gain to ج.م205, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 596% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م148 per share.Reported Earnings • May 27First quarter 2023 earnings released: EPS: ج.م17.14 (vs ج.م20.31 in 1Q 2022)First quarter 2023 results: EPS: ج.م17.14 (down from ج.م20.31 in 1Q 2022). Revenue: ج.م1.50b (down 64% from 1Q 2022). Net income: ج.م3.93b (down 16% from 1Q 2022). Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Chemicals industry in Egypt. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth.Upcoming Dividend • May 03Upcoming dividend of ج.م15.00 per share at 8.6% yieldEligible shareholders must have bought the stock before 10 May 2023. Payment date: 14 May 2023. Trailing yield: 8.6%. Within top quartile of Egyptian dividend payers (8.1%). Higher than average of industry peers (6.8%).Price Target Changed • Apr 03Price target increased by 7.5% to ج.م187Up from ج.م174, the current price target is an average from 5 analysts. New target price is 18% above last closing price of ج.م158. Stock is up 49% over the past year. The company is forecast to post earnings per share of ج.م29.41 for next year compared to ج.م20.91 last year.Valuation Update With 7 Day Price Move • Mar 29Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ج.م160, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 5x in the Chemicals industry in Egypt. Total returns to shareholders of 394% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م124 per share.Price Target Changed • Mar 06Price target increased by 12% to ج.م174Up from ج.م155, the current price target is an average from 5 analysts. New target price is 20% above last closing price of ج.م145. Stock is up 60% over the past year. The company is forecast to post earnings per share of ج.م29.41 for next year compared to ج.م20.91 last year.Price Target Changed • Dec 01Price target increased to ج.م145Up from ج.م132, the current price target is an average from 4 analysts. New target price is 9.1% above last closing price of ج.م133. Stock is up 41% over the past year. The company is forecast to post earnings per share of ج.م29.33 for next year compared to ج.م20.91 last year.Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 12 non-independent directors. Director Hesham Mohamed El Din was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Sep 18Second quarter 2022 earnings released: EPS: ج.م7.18 (vs ج.م6.04 in 2Q 2021)Second quarter 2022 results: EPS: ج.م7.18 (up from ج.م6.04 in 2Q 2021). Revenue: ج.م4.50b (up 106% from 2Q 2021). Net income: ج.م1.65b (up 19% from 2Q 2021). Profit margin: 37% (down from 63% in 2Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to decline by 5.6% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Egypt are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.Price Target Changed • Jun 22Price target increased to ج.م139Up from ج.م125, the current price target is an average from 3 analysts. New target price is 39% above last closing price of ج.م99.60. Stock is up 32% over the past year. The company is forecast to post earnings per share of ج.م28.39 for next year compared to ج.م20.91 last year.Valuation Update With 7 Day Price Move • May 01Investor sentiment improved over the past weekAfter last week's 15% share price gain to ج.م110, the stock trades at a forward P/E ratio of 4x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 99% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م172 per share.Price Target Changed • Apr 27Price target increased to ج.م125Up from ج.م112, the current price target is an average from 4 analysts. New target price is 26% above last closing price of ج.م98.98. Stock is up 37% over the past year. The company is forecast to post earnings per share of ج.م30.05 for next year compared to ج.م20.91 last year.Board Change • Apr 27No independent directorsThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: No independent directors. 12 non-independent directors. Director Hesham Mohamed El Din was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity.Upcoming Dividend • Mar 31Inaugural dividend of ج.م7.00 per shareEligible shareholders must have bought the stock before 07 April 2022. Payment date: 10 April 2022. The company is not currently making a profit but it is cash flow positive. The company last paid an ordinary dividend in April 2017. The average dividend yield among industry peers is 4.6%.Buying Opportunity • Mar 23Now 20% undervaluedOver the last 90 days, the stock is up 17%. The fair value is estimated to be ج.م134, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13% per annum over the last 3 years.Major Estimate Revision • Mar 18Consensus revenue estimates increase by 39%The consensus outlook for revenues in 2022 has improved. 2022 revenue forecast increased from ج.م12.3b to ج.م17.1b. EPS estimate increased from ج.م20.01 to ج.م27.90 per share. Net income forecast to grow 51% next year vs 21% growth forecast for Chemicals industry in Egypt. Consensus price target up from ج.م112 to ج.م121. Share price rose 13% to ج.م102 over the past week.Price Target Changed • Mar 15Price target increased to ج.م121Up from ج.م112, the current price target is an average from 4 analysts. New target price is 32% above last closing price of ج.م91.21. Stock is up 20% over the past year. The company is forecast to post earnings per share of ج.م21.05 for next year compared to ج.م10.86 last year.Buying Opportunity • Feb 21Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 8.4%. The fair value is estimated to be ج.م107, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.4% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.Buying Opportunity • Jan 21Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 9.6%. The fair value is estimated to be ج.م113, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.4% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.Price Target Changed • Oct 19Price target increased to ج.م111Up from ج.م103, the current price target is an average from 5 analysts. New target price is 16% above last closing price of ج.م95.13. Stock is up 104% over the past year. The company is forecast to post earnings per share of ج.م15.08 for next year compared to ج.م10.86 last year.Price Target Changed • Aug 26Price target increased to ج.م103Up from ج.م96.12, the current price target is an average from 5 analysts. New target price is 26% above last closing price of ج.م82.18. Stock is up 60% over the past year.Reported Earnings • Jun 20First quarter 2021 earnings released: EPS ج.م3.46 (vs ج.م2.33 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ج.م2.00b (up 11% from 1Q 2020). Net income: ج.م792.7m (up 49% from 1Q 2020). Profit margin: 40% (up from 30% in 1Q 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.Major Estimate Revision • Jun 18Consensus EPS estimates increase to ج.م14.51The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from ج.م8.65b to ج.م9.34b. EPS estimate increased from ج.م11.28 to ج.م14.51 per share. Net income forecast to grow 3.9% next year vs 3.9% growth forecast for Chemicals industry in Egypt. Consensus price target up from ج.م96.12 to ج.م102. Share price was steady at ج.م75.66 over the past week.Upcoming Dividend • Apr 19Inaugural dividend of ج.م3.50 per shareEligible shareholders must have bought the stock before 26 April 2021. Payment date: 28 April 2021. The company last paid an ordinary dividend in May 2019. The average dividend yield among industry peers is 5.9%.Is New 90 Day High Low • Feb 17New 90-day high: ج.م79.28The company is up 63% from its price of ج.م48.64 on 19 November 2020. The Egyptian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ج.م83.31 per share.Is New 90 Day High Low • Jan 26New 90-day high: ج.م70.31The company is up 51% from its price of ج.م46.45 on 28 October 2020. The Egyptian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 24% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ج.م82.02 per share.Price Target Changed • Jan 21Price target raised to ج.م86.93Up from ج.م81.05, the current price target is an average from 2 analysts. The new target price is 26% above the current share price of ج.م68.87. As of last close, the stock is up 22% over the past year.Valuation Update With 7 Day Price Move • Dec 21Investor sentiment improved over the past weekAfter last week's 15% share price gain to ج.م68.14, the stock is trading at a trailing P/E ratio of 8.3x, up from the previous P/E ratio of 7.2x. This compares to an average P/E of 10x in the Chemicals industry in Egypt. Total return to shareholders over the past three years is a loss of 19%.Major Estimate Revision • Dec 17Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate increased from ج.م7.79 to ج.م8.89. Revenue estimate for the same period was approximately flat at ج.م7.74b. Net income is expected to shrink by 4.9% next year compared to 5.8% growth forecast for the Chemicals industry in Egypt . The consensus price target increased from ج.م81.05 to ج.م81.55. Share price is up 1.4% to ج.م57.99 over the past week.Is New 90 Day High Low • Nov 26New 90-day high: ج.م53.50The company is up 4.0% from its price of ج.م51.52 on 27 August 2020. The Egyptian market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ج.م49.72 per share.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: MFPC 10년 미만 동안 배당금을 지급해 왔으며 이 기간 동안 지급액은 휘발성이었습니다.배당금 증가: MFPC 의 배당금 지급이 증가했지만 회사는 9 년 동안만 배당금을 지급했습니다.배당 수익률 vs 시장Misr Fertilizer Production 배당 수익률 vs 시장MFPC의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (MFPC)5.8%시장 하위 25% (EG)1.3%시장 상위 25% (EG)6.1%업계 평균 (Chemicals)6.2%분석가 예측 (MFPC) (최대 3년)5.8%주목할만한 배당금: MFPC 의 배당금( 5.77% )은 EG 시장에서 배당금 지급자의 하위 25%( 1.3% )보다 높습니다.고배당: MFPC 의 배당금( 5.77% )은 EG 시장에서 배당금 지급자의 상위 25%( 6.11% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 합리적인 지급 비율 ( 64.1% )을 통해 MFPC 의 배당금 지급은 수익으로 충당됩니다.주주 현금 배당현금 흐름 범위: 현금 지급 비율 ( 135.2% )이 높기 때문에 MFPC 의 배당금 지급은 현금 흐름으로 잘 충당되지 않습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YEG 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/25 18:21종가2026/05/25 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Misr Fertilizer Production Company는 4명의 분석가가 다루고 있습니다. 이 중 3명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Soha SaniourArqaam Capital Research Offshore S.A.L.Yousef El HusseiniEFG-Hermes ResearchAmany ShaabanPrime Research1명의 분석가 더 보기
Upcoming Dividend • Mar 27Upcoming dividend of ج.م2.00 per shareEligible shareholders must have bought the stock before 03 April 2024. Payment date: 07 April 2024. Payout ratio is a comfortable 46% but the company is paying out more than the cash it is generating. Trailing yield: 3.1%. Lower than top quartile of Egyptian dividend payers (6.3%). Lower than average of industry peers (4.9%).
Upcoming Dividend • May 03Upcoming dividend of ج.م15.00 per share at 8.6% yieldEligible shareholders must have bought the stock before 10 May 2023. Payment date: 14 May 2023. Trailing yield: 8.6%. Within top quartile of Egyptian dividend payers (8.1%). Higher than average of industry peers (6.8%).
Upcoming Dividend • Mar 31Inaugural dividend of ج.م7.00 per shareEligible shareholders must have bought the stock before 07 April 2022. Payment date: 10 April 2022. The company is not currently making a profit but it is cash flow positive. The company last paid an ordinary dividend in April 2017. The average dividend yield among industry peers is 4.6%.
Upcoming Dividend • Apr 19Inaugural dividend of ج.م3.50 per shareEligible shareholders must have bought the stock before 26 April 2021. Payment date: 28 April 2021. The company last paid an ordinary dividend in May 2019. The average dividend yield among industry peers is 5.9%.
Price Target Changed • May 20Price target increased by 16% to ج.م36.78Up from ج.م31.83, the current price target is an average from 4 analysts. New target price is 15% below last closing price of ج.م43.50. Stock is up 57% over the past year. The company is forecast to post earnings per share of ج.م6.00 for next year compared to ج.م3.94 last year.
Board Change • May 20No independent directorsThere are 7 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: No independent directors. 11 non-independent directors. Director Hussein Mohamed Abdel Salam Badawi was the last director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity.
공시 • Mar 13Misr Fertilizer Production Company, Annual General Meeting, Apr 06, 2026Misr Fertilizer Production Company, Annual General Meeting, Apr 06, 2026, at 15:30 Egypt Standard Time. Location: cairo Egypt
Reported Earnings • May 17First quarter 2025 earnings released: EPS: ج.م1.35 (vs ج.م3.68 in 1Q 2024)First quarter 2025 results: EPS: ج.م1.35 (down from ج.م3.68 in 1Q 2024). Revenue: ج.م6.34b (up 32% from 1Q 2024). Net income: ج.م2.81b (down 63% from 1Q 2024). Profit margin: 44% (down from 159% in 1Q 2024). Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Chemicals industry in Africa. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth.
Board Change • May 14No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 9 non-independent directors. Director Yasser El-Din was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Mar 24Misr Fertilizer Production Company, Annual General Meeting, Apr 12, 2025Misr Fertilizer Production Company, Annual General Meeting, Apr 12, 2025, at 12:00 Egypt Standard Time. Location: cairo Egypt
New Risk • Oct 08New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.3% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings are forecast to decline by an average of 0.3% per year for the foreseeable future. High level of non-cash earnings (32% accrual ratio). Minor Risk Dividend is not well covered by cash flows (236% cash payout ratio).
Reported Earnings • May 27First quarter 2024 earnings released: EPS: ج.م3.68 (vs ج.م1.18 in 1Q 2023)First quarter 2024 results: EPS: ج.م3.68 (up from ج.م1.18 in 1Q 2023). Revenue: ج.م4.80b (down 5.7% from 1Q 2023). Net income: ج.م7.65b (up 212% from 1Q 2023). Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in Egypt. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has increased by 82% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • May 19Investor sentiment improves as stock rises 29%After last week's 29% share price gain to ج.م51.82, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 640% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م23.36 per share.
New Risk • May 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Egyptian stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (193% cash payout ratio). Share price has been volatile over the past 3 months (11% average weekly change).
Valuation Update With 7 Day Price Move • Apr 24Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ج.م47.37, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 643% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م20.64 per share.
Upcoming Dividend • Mar 27Upcoming dividend of ج.م2.00 per shareEligible shareholders must have bought the stock before 03 April 2024. Payment date: 07 April 2024. Payout ratio is a comfortable 46% but the company is paying out more than the cash it is generating. Trailing yield: 3.1%. Lower than top quartile of Egyptian dividend payers (6.3%). Lower than average of industry peers (4.9%).
Valuation Update With 7 Day Price Move • Mar 18Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to ج.م48.30, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 688% over the past three years.
Valuation Update With 7 Day Price Move • Feb 28Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ج.م62.13, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 835% over the past three years.
Reported Earnings • Feb 20Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: ج.م2.87 (down from ج.م31.67 in FY 2022). Revenue: ج.م5.96b (down 68% from FY 2022). Net income: ج.م5.97b (down 18% from FY 2022). Revenue missed analyst estimates by 67%. Earnings per share (EPS) also missed analyst estimates by 91%. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 7.3% growth forecast for the Chemicals industry in Egypt. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Jan 22Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ج.م85.03, the stock trades at a forward P/E ratio of 3x. Average forward P/E is 7x in the Chemicals industry in Egypt. Total returns to shareholders of 54% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م132 per share.
New Risk • Jan 08New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 8x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (29% average weekly change). Shareholders have been substantially diluted in the past year (over 8x increase in shares outstanding). Minor Risk Dividend is not well covered by cash flows (394% cash payout ratio).
Buying Opportunity • Dec 28Now 92% undervalued after recent price dropOver the last 90 days, the stock is down 97%. The fair value is estimated to be ج.م122, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 40% over the last 3 years. Earnings per share has grown by 43%. For the next 3 years, revenue is forecast to grow by 8.1% per annum. Earnings is also forecast to grow by 2.4% per annum over the same time period.
Valuation Update With 7 Day Price Move • Dec 10Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ج.م446, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 7x in the Chemicals industry in Egypt. Total returns to shareholders of 860% over the past three years.
Reported Earnings • Dec 02Third quarter 2023 earnings released: EPS: ج.م5.47 (vs ج.م5.78 in 3Q 2022)Third quarter 2023 results: EPS: ج.م5.47 (down from ج.م5.78 in 3Q 2022). Revenue: ج.م3.82b (up 5.3% from 3Q 2022). Net income: ج.م1.25b (down 5.5% from 3Q 2022). Profit margin: 33% (down from 37% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.0% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Egypt. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has increased by 120% per year, which means it is tracking significantly ahead of earnings growth.
Price Target Changed • Nov 29Price target increased by 15% to ج.م285Up from ج.م248, the current price target is an average from 7 analysts. New target price is 47% below last closing price of ج.م540. Stock is up 307% over the past year. The company is forecast to post earnings per share of ج.م31.76 for next year compared to ج.م31.67 last year.
Valuation Update With 7 Day Price Move • Oct 31Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ج.م550, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 9x in the Chemicals industry in Egypt. Total returns to shareholders of 1,362% over the past three years.
Valuation Update With 7 Day Price Move • Oct 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ج.م377, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 7x in the Chemicals industry in Egypt. Total returns to shareholders of 918% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م189 per share.
Price Target Changed • Oct 10Price target increased by 7.5% to ج.م248Up from ج.م231, the current price target is an average from 7 analysts. New target price is 23% below last closing price of ج.م321. Stock is up 195% over the past year. The company is forecast to post earnings per share of ج.م31.99 for next year compared to ج.م31.67 last year.
Valuation Update With 7 Day Price Move • Sep 19Investor sentiment improves as stock rises 33%After last week's 33% share price gain to ج.م333, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 7x in the Chemicals industry in Egypt. Total returns to shareholders of 756% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م202 per share.
Price Target Changed • Sep 13Price target increased by 12% to ج.م247Up from ج.م221, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of ج.م251. Stock is up 136% over the past year. The company is forecast to post earnings per share of ج.م30.39 for next year compared to ج.م31.67 last year.
Reported Earnings • Aug 31Second quarter 2023 earnings released: EPS: ج.م6.63 (vs ج.م7.18 in 2Q 2022)Second quarter 2023 results: EPS: ج.م6.63 (down from ج.م7.18 in 2Q 2022). Revenue: ج.م4.33b (down 3.7% from 2Q 2022). Net income: ج.م1.52b (down 7.7% from 2Q 2022). Profit margin: 35% (down from 37% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Egypt. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has increased by 68% per year, which means it is tracking significantly ahead of earnings growth.
Price Target Changed • Jul 31Price target increased by 7.7% to ج.م227Up from ج.م211, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of ج.م230. Stock is up 131% over the past year. The company is forecast to post earnings per share of ج.م29.19 for next year compared to ج.م31.67 last year.
Valuation Update With 7 Day Price Move • Jul 09Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ج.م190, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 410% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م151 per share.
Price Target Changed • Jun 29Price target increased by 8.4% to ج.م195Up from ج.م180, the current price target is an average from 5 analysts. New target price is 16% below last closing price of ج.م232. Stock is up 146% over the past year. The company is forecast to post earnings per share of ج.م25.57 for next year compared to ج.م31.67 last year.
New Risk • Jun 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Egyptian stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 6.2% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.9% average weekly change).
Valuation Update With 7 Day Price Move • Jun 13Investor sentiment improves as stock rises 29%After last week's 29% share price gain to ج.م205, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 596% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م148 per share.
Reported Earnings • May 27First quarter 2023 earnings released: EPS: ج.م17.14 (vs ج.م20.31 in 1Q 2022)First quarter 2023 results: EPS: ج.م17.14 (down from ج.م20.31 in 1Q 2022). Revenue: ج.م1.50b (down 64% from 1Q 2022). Net income: ج.م3.93b (down 16% from 1Q 2022). Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Chemicals industry in Egypt. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth.
Upcoming Dividend • May 03Upcoming dividend of ج.م15.00 per share at 8.6% yieldEligible shareholders must have bought the stock before 10 May 2023. Payment date: 14 May 2023. Trailing yield: 8.6%. Within top quartile of Egyptian dividend payers (8.1%). Higher than average of industry peers (6.8%).
Price Target Changed • Apr 03Price target increased by 7.5% to ج.م187Up from ج.م174, the current price target is an average from 5 analysts. New target price is 18% above last closing price of ج.م158. Stock is up 49% over the past year. The company is forecast to post earnings per share of ج.م29.41 for next year compared to ج.م20.91 last year.
Valuation Update With 7 Day Price Move • Mar 29Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ج.م160, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 5x in the Chemicals industry in Egypt. Total returns to shareholders of 394% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م124 per share.
Price Target Changed • Mar 06Price target increased by 12% to ج.م174Up from ج.م155, the current price target is an average from 5 analysts. New target price is 20% above last closing price of ج.م145. Stock is up 60% over the past year. The company is forecast to post earnings per share of ج.م29.41 for next year compared to ج.م20.91 last year.
Price Target Changed • Dec 01Price target increased to ج.م145Up from ج.م132, the current price target is an average from 4 analysts. New target price is 9.1% above last closing price of ج.م133. Stock is up 41% over the past year. The company is forecast to post earnings per share of ج.م29.33 for next year compared to ج.م20.91 last year.
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 12 non-independent directors. Director Hesham Mohamed El Din was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Sep 18Second quarter 2022 earnings released: EPS: ج.م7.18 (vs ج.م6.04 in 2Q 2021)Second quarter 2022 results: EPS: ج.م7.18 (up from ج.م6.04 in 2Q 2021). Revenue: ج.م4.50b (up 106% from 2Q 2021). Net income: ج.م1.65b (up 19% from 2Q 2021). Profit margin: 37% (down from 63% in 2Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to decline by 5.6% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Egypt are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.
Price Target Changed • Jun 22Price target increased to ج.م139Up from ج.م125, the current price target is an average from 3 analysts. New target price is 39% above last closing price of ج.م99.60. Stock is up 32% over the past year. The company is forecast to post earnings per share of ج.م28.39 for next year compared to ج.م20.91 last year.
Valuation Update With 7 Day Price Move • May 01Investor sentiment improved over the past weekAfter last week's 15% share price gain to ج.م110, the stock trades at a forward P/E ratio of 4x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 99% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م172 per share.
Price Target Changed • Apr 27Price target increased to ج.م125Up from ج.م112, the current price target is an average from 4 analysts. New target price is 26% above last closing price of ج.م98.98. Stock is up 37% over the past year. The company is forecast to post earnings per share of ج.م30.05 for next year compared to ج.م20.91 last year.
Board Change • Apr 27No independent directorsThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: No independent directors. 12 non-independent directors. Director Hesham Mohamed El Din was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity.
Upcoming Dividend • Mar 31Inaugural dividend of ج.م7.00 per shareEligible shareholders must have bought the stock before 07 April 2022. Payment date: 10 April 2022. The company is not currently making a profit but it is cash flow positive. The company last paid an ordinary dividend in April 2017. The average dividend yield among industry peers is 4.6%.
Buying Opportunity • Mar 23Now 20% undervaluedOver the last 90 days, the stock is up 17%. The fair value is estimated to be ج.م134, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13% per annum over the last 3 years.
Major Estimate Revision • Mar 18Consensus revenue estimates increase by 39%The consensus outlook for revenues in 2022 has improved. 2022 revenue forecast increased from ج.م12.3b to ج.م17.1b. EPS estimate increased from ج.م20.01 to ج.م27.90 per share. Net income forecast to grow 51% next year vs 21% growth forecast for Chemicals industry in Egypt. Consensus price target up from ج.م112 to ج.م121. Share price rose 13% to ج.م102 over the past week.
Price Target Changed • Mar 15Price target increased to ج.م121Up from ج.م112, the current price target is an average from 4 analysts. New target price is 32% above last closing price of ج.م91.21. Stock is up 20% over the past year. The company is forecast to post earnings per share of ج.م21.05 for next year compared to ج.م10.86 last year.
Buying Opportunity • Feb 21Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 8.4%. The fair value is estimated to be ج.م107, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.4% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.
Buying Opportunity • Jan 21Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 9.6%. The fair value is estimated to be ج.م113, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.4% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.
Price Target Changed • Oct 19Price target increased to ج.م111Up from ج.م103, the current price target is an average from 5 analysts. New target price is 16% above last closing price of ج.م95.13. Stock is up 104% over the past year. The company is forecast to post earnings per share of ج.م15.08 for next year compared to ج.م10.86 last year.
Price Target Changed • Aug 26Price target increased to ج.م103Up from ج.م96.12, the current price target is an average from 5 analysts. New target price is 26% above last closing price of ج.م82.18. Stock is up 60% over the past year.
Reported Earnings • Jun 20First quarter 2021 earnings released: EPS ج.م3.46 (vs ج.م2.33 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ج.م2.00b (up 11% from 1Q 2020). Net income: ج.م792.7m (up 49% from 1Q 2020). Profit margin: 40% (up from 30% in 1Q 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
Major Estimate Revision • Jun 18Consensus EPS estimates increase to ج.م14.51The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from ج.م8.65b to ج.م9.34b. EPS estimate increased from ج.م11.28 to ج.م14.51 per share. Net income forecast to grow 3.9% next year vs 3.9% growth forecast for Chemicals industry in Egypt. Consensus price target up from ج.م96.12 to ج.م102. Share price was steady at ج.م75.66 over the past week.
Upcoming Dividend • Apr 19Inaugural dividend of ج.م3.50 per shareEligible shareholders must have bought the stock before 26 April 2021. Payment date: 28 April 2021. The company last paid an ordinary dividend in May 2019. The average dividend yield among industry peers is 5.9%.
Is New 90 Day High Low • Feb 17New 90-day high: ج.م79.28The company is up 63% from its price of ج.م48.64 on 19 November 2020. The Egyptian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ج.م83.31 per share.
Is New 90 Day High Low • Jan 26New 90-day high: ج.م70.31The company is up 51% from its price of ج.م46.45 on 28 October 2020. The Egyptian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 24% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ج.م82.02 per share.
Price Target Changed • Jan 21Price target raised to ج.م86.93Up from ج.م81.05, the current price target is an average from 2 analysts. The new target price is 26% above the current share price of ج.م68.87. As of last close, the stock is up 22% over the past year.
Valuation Update With 7 Day Price Move • Dec 21Investor sentiment improved over the past weekAfter last week's 15% share price gain to ج.م68.14, the stock is trading at a trailing P/E ratio of 8.3x, up from the previous P/E ratio of 7.2x. This compares to an average P/E of 10x in the Chemicals industry in Egypt. Total return to shareholders over the past three years is a loss of 19%.
Major Estimate Revision • Dec 17Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate increased from ج.م7.79 to ج.م8.89. Revenue estimate for the same period was approximately flat at ج.م7.74b. Net income is expected to shrink by 4.9% next year compared to 5.8% growth forecast for the Chemicals industry in Egypt . The consensus price target increased from ج.م81.05 to ج.م81.55. Share price is up 1.4% to ج.م57.99 over the past week.
Is New 90 Day High Low • Nov 26New 90-day high: ج.م53.50The company is up 4.0% from its price of ج.م51.52 on 27 August 2020. The Egyptian market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ج.م49.72 per share.